Development of novel predictive 2D and 3D in vitro models for anti-leishmanial drug testing
The failure rates of drugs once they reach clinical trials are high, with estimates up to nearly 90%. One reason is the lack of biologically relevant models in which potential drug candidates are screened, evaluated and selected during discovery and development phases. Leishmaniasis is a disease tha...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
London School of Hygiene and Tropical Medicine (University of London)
2018
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.740139 |